These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 3659049)
1. Management of hormone resistant stage C and D prostatic cancer. Khoury S Prog Clin Biol Res; 1987; 243B():513-20. PubMed ID: 3659049 [No Abstract] [Full Text] [Related]
2. Management of hormone resistant stage C and D prostatic cancer. Khoury S Prog Clin Biol Res; 1989; 303():347-52. PubMed ID: 2674996 [No Abstract] [Full Text] [Related]
3. The role of radiotherapy in the treatment of hormone-resistant stage C lesions. Bagshaw MA Prog Clin Biol Res; 1987; 243B():473-8. PubMed ID: 3659043 [No Abstract] [Full Text] [Related]
4. Primary treatment of stage C and D prostatic cancer: conclusions. Jardin A Prog Clin Biol Res; 1987; 243B():455-6. PubMed ID: 3659040 [No Abstract] [Full Text] [Related]
5. Experimental and theoretical basis for hormonal treatment of prostatic cancer. Carter HB; Isaacs JT Semin Urol; 1988 Nov; 6(4):262-8. PubMed ID: 3068765 [No Abstract] [Full Text] [Related]
7. Prognostic factors in stage D2 prostate cancer; important implications for future trials: results of a cooperative intergroup study (INT.0036). The National Cancer Institute Intergroup Study #0036. Eisenberger MA; Crawford ED; Wolf M; Blumenstein B; McLeod DG; Benson R; Dorr FA; Benson M; Spaulding JT Semin Oncol; 1994 Oct; 21(5):613-9. PubMed ID: 7939752 [No Abstract] [Full Text] [Related]
20. Obstructive uropathy from locally advanced and metastatic prostate cancer: an old problem with new therapies. Friedlander JI; Duty BD; Okeke Z; Smith AD J Endourol; 2012 Feb; 26(2):102-9. PubMed ID: 22192109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]